Tecan establishes direct sales and specialist lab automation service operations in India
Strengthening local presence and customer support in a high-growth life sciences market
28 May 2026Industry news

Tecan has established direct operations in India with a dedicated sales and specialist service team based in Gurugram, near New Delhi. The new Tecan India entity will support pharmaceutical, biotechnology, academic and diagnostic customers across the country, strengthening local collaboration, customer engagement and responsive service in one of the world’s fastest-growing life sciences markets.
Strengthening Tecan’s presence in the Indian life sciences market
The launch of Tecan India was celebrated with a ribbon-cutting ceremony at the new office in Gurugram, reflecting the strategic importance of India as a hub for innovation, clinical research and healthcare development.
For more than a decade, Tecan has supported customers in India through its distributor partner Bioscreen. With the establishment of a direct presence, Tecan will continue to collaborate closely with Bioscreen, combining the distributor’s local market expertise with Tecan’s enhanced, on-the-ground customer engagement and technical support.
Direct operations to enhance customer support and collaboration
The creation of Tecan India brings the company closer to its growing customer base across key sectors, including pharmaceutical development, biotechnology research, academic laboratories and clinical diagnostics. The dedicated local sales and specialist service team will provide:
- More direct and frequent customer interactions
- Faster, locally delivered service and maintenance for Tecan’s laboratory automation solutions
- Closer collaboration on workflow optimization and scaling of research and diagnostic applications
By operating directly in India, Tecan aims to help laboratories accelerate innovation, improve efficiency and support the delivery of high-quality results in drug discovery, genomics, proteomics and clinical testing.
This strategic move reflects Tecan’s long-term view of India as a critical market for laboratory automation, driven by expanding R&D investment, a strong talent pool and increasing demand for high-throughput, reliable and scalable laboratory solutions.
Mukta Acharya, EVP and Head of Tecan’s Life Sciences business, said, “India is a key market for the future of life sciences, with strong momentum across CROs, pharma, biotech and diagnostics. Establishing a direct presence allows us to be closer to our customers, deepen collaboration and further strengthen the value we deliver locally.”
Want the latest science news straight to your inbox? Become a SelectScience member for free today>>
Frequently asked questions
How will Tecan India support the Indian pharmaceutical, biotechnology, academic and diagnostic sectors?
Tecan India will support pharmaceutical development, biotechnology research, academic laboratories and clinical diagnostic customers across India by providing more direct and frequent customer interactions, faster locally delivered service and maintenance for Tecan’s laboratory automation solutions, and closer collaboration on workflow optimization and scaling of research and diagnostic applications.
By operating directly in India, Tecan aims to help laboratories accelerate innovation, improve efficiency and support high-quality results in drug discovery, genomics, proteomics and clinical testing.
Why is India a strategic market for Tecan’s laboratory automation business?
India is described by Tecan as a key market for the future of life sciences, with strong momentum across contract research organizations (CROs), pharma, biotech and diagnostics. According to Mukta Acharya, EVP and Head of Tecan’s Life Sciences business, establishing a direct presence allows Tecan to be closer to customers, deepen collaboration and strengthen the value delivered locally.
This strategic move reflects Tecan’s long-term view of India as a critical market for laboratory automation, driven by expanding R&D investment, a strong talent pool and increasing demand for high-throughput, reliable and scalable laboratory solutions, and builds on the company’s broader regional expansion in high-growth Asian markets such as South Korea.